◄ back to all posts

CTLT: Catalent Inc. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9,438.00
Enterprise Value ($M) 10,677.16
Book Value ($M) 1,529.40
Book Value / Share 10.52
Price / Book 5.67
NCAV ($M) 1,083.40
NCAV / Share 6.94
Price / NCAV 8.00

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.61
Current Ratio 2.05

Balance Sheet (mrq) ($M)
Current Assets 1,083.40
Assets 4,499.80
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,075.40
Operating Income 234.20
Net Income 109.80
Earnings Per Share Diluted 0.87
Earnings Per Share Basic 0.88

Cash Flow Statement (mra) ($M)
Cash From Operations 299.50
Cash from Investing -309.00
Cash from Financing -309.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Price T Rowe Associates Inc /md/ 15.50 1.76
2020-02-13 13G/A Henderson Group Plc 11.30 10.98
2020-02-12 13G/A Vanguard Group Inc 9.29 3.12
2020-01-10 13G/A BlackRock Inc. 10.00 13.87
2019-12-05 13G/A JP Morgan Chase & Co 4.40 -21.29
2019-05-28 13D Green Equity Investors Vii, L.p. 9.00
2018-02-13 13G/A FMR LLC / Fidelity 2.76 -53.73
2018-02-06 13G/A Janus Capital Management Llc 4.70 -17.29
2017-02-14 13G/A Blackstone Holdings III L.P. 0.00 -100.00
2017-02-10 13G/A Vestar Capital Partners V L P 0.00
2016-01-19 13G/A Genstar IV GP LLC 2.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-02-03 10-Q CTLT / Catalent Inc. 10-Q – Quarterly Report – 10-Q
2019-11-05 10-Q CTLT / Catalent Inc. 10-Q – Quarterly Report – 10-Q
2019-08-27 10-K CTLT / Catalent Inc. 10-K – Annual Report – 10-K
2019-05-07 10-Q CTLT / Catalent Inc. 10-Q Quarterly Report 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 161,150 1,838,200 8.77
2020-02-13 63,008 629,600 10.01
2020-02-12 45,765 649,900 7.04
2020-02-11 74,004 820,900 9.01
2020-02-10 66,874 996,200 6.71

(click for more detail)

Similar Companies
BMY – Bristol-Myers Squibb Co. BXLT – Baxalta Incorporated
CBM – Cambrex Corp. EBS – Emergent Biosolutions, Inc.
HSP – Hospira


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
Holistic